Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression

View source ↗

Summary

This entry describes a real-world clinical trial evaluating esketamine nasal spray for treatment-resistant depression, currently recruiting to assess outcomes a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spravato (esketamine nasal spray) (Esketamine)

Snippet

Sponsor: Riccardo Guglielmo | Conditions: Depression and Quality of Life, Treatment Resistant Depression (TRD) | Status: RECRUITING